scholarly article | Q13442814 |
P2093 | author name string | David L Williams | |
Chieko Mineo | |||
Philip W Shaul | |||
Margarita de la Llera-Moya | |||
Ivan S Yuhanna | |||
Margery A Connelly | |||
David L Silver | |||
Yves L Marcel | |||
Chatchawin Assanasen | |||
Divya Seetharam | |||
P2860 | cites work | Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles | Q22011017 |
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis | Q24315133 | ||
Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I | Q24673266 | ||
Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity | Q28142263 | ||
START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins | Q28143812 | ||
At the acidic edge: emerging functions for lysosomal membrane proteins | Q28182104 | ||
Identification of small PDZK1-associated protein, DD96/MAP17, as a regulator of PDZK1 and plasma high density lipoprotein levels | Q28204853 | ||
Targeted Disruption of the PDZK1 Gene in Mice Causes Tissue-specific Depletion of the High Density Lipoprotein Receptor Scavenger Receptor Class B Type I and Altered Lipoprotein Metabolism | Q28208721 | ||
A carboxyl-terminal PDZ-interacting domain of scavenger receptor B, type I is essential for cell surface expression in liver | Q28214792 | ||
Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein | Q28295187 | ||
Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family | Q28298311 | ||
Cloning, sequencing, and expression of a cDNA encoding rat LIMP II, a novel 74-kDa lysosomal membrane protein related to the surface adhesion protein CD36 | Q28574644 | ||
Dimerization of the scavenger receptor class B type I: formation, function, and localization in diverse cells and tissues | Q28582095 | ||
Atheroprotective mechanisms of HDL. | Q33688098 | ||
The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism | Q33901922 | ||
Cholesterol modification of proteins | Q34101243 | ||
The sterol-sensing domain: multiple families, a unique role? | Q34121980 | ||
HDL and arteriosclerosis: beyond reverse cholesterol transport | Q34554267 | ||
HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI–dependent manner | Q34997795 | ||
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. | Q36056673 | ||
High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase | Q38299352 | ||
Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake | Q38330118 | ||
High-density lipoprotein--the clinical implications of recent studies | Q38700033 | ||
Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis | Q40137011 | ||
Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism | Q40709438 | ||
Establishment of an immortalized fetal intrapulmonary artery endothelial cell line. | Q40941629 | ||
Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors | Q41052382 | ||
Cellular cholesterol efflux mediated by cyclodextrins | Q41324065 | ||
17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization | Q42446233 | ||
Expression cloning of SR-BI, a CD36-related class B scavenger receptor | Q42834565 | ||
Analysis of chimeric receptors shows that multiple distinct functional activities of scavenger receptor, class B, type I (SR-BI), are localized to the extracellular receptor domain | Q43585944 | ||
High-density lipoprotein restores endothelial function in hypercholesterolemic men. | Q43933064 | ||
Ile (476), a constituent of di-leucine-based motif of a major lysosomal membrane protein, LGP85/LIMP II, is important for its proper distribution in late endosomes and lysosomes | Q44041047 | ||
High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases | Q44269059 | ||
Separation of Lipid Transport Functions by Mutations in the Extracellular Domain of Scavenger Receptor Class B, Type I | Q44429253 | ||
A physical and functional link between cholesterol and tetraspanins | Q44561355 | ||
Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain | Q44984062 | ||
Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs | Q45081451 | ||
High-density lipoprotein stimulates myocardial perfusion in vivo. | Q45151846 | ||
Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain | Q47921201 | ||
SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells | Q48010257 | ||
Murine Model of Niemann-Pick C Disease: Mutation in a Cholesterol Homeostasis Gene | Q48047362 | ||
High density lipoprotein-induced signaling of the MAPK pathway involves scavenger receptor type BI-mediated activation of Ras. | Q51838941 | ||
Effect of LpA-I composition and structure on cholesterol transfer between lipoproteins | Q72591848 | ||
Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor | Q72992440 | ||
Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation | Q73133867 | ||
Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution | Q73334108 | ||
Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium | Q73575785 | ||
High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI | Q74241751 | ||
Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles | Q74456765 | ||
Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface | Q74580044 | ||
Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein A-I concentration | Q77502910 | ||
Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern | Q77614441 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 969-977 | |
P577 | publication date | 2005-03-24 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling | |
P478 | volume | 115 |
Q91713954 | A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis |
Q35957168 | Activation of Endothelial Nitric Oxide (eNOS) Occurs through Different Membrane Domains in Endothelial Cells |
Q34116819 | Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx |
Q38032197 | Antitumor activity of mushroom polysaccharides: a review |
Q64054532 | Beta cell secretion of miR-375 to HDL is inversely associated with insulin secretion |
Q37514264 | Beta-glucans as immunostimulant in vertebrates and invertebrates. |
Q33435708 | Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease |
Q37421145 | Caveolin-1 mediates endotoxin inhibition of endothelin-1-induced endothelial nitric oxide synthase activity in liver sinusoidal endothelial cells |
Q47340915 | Cholesterol trafficking and raft-like membrane domain composition mediate scavenger receptor class B type 1-dependent lipid sensing in intestinal epithelial cells |
Q37033745 | Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice |
Q46918406 | Diabetic HDL-associated myristic acid inhibits acetylcholine-induced nitric oxide generation by preventing the association of endothelial nitric oxide synthase with calmodulin |
Q36929420 | HDL and endothelial protection. |
Q35021594 | HDL cholesterol efflux capacity and incident cardiovascular events |
Q36765386 | HDL signaling and protection against coronary artery atherosclerosis in mice |
Q35238369 | High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists |
Q37041783 | High-Density Lipoproteins, Endothelial Function, and Mendelian Randomization |
Q34714464 | High-density lipoprotein: a novel target for antirestenosis therapy |
Q37718866 | High-density lipoproteins, platelets and the pathogenesis of atherosclerosis |
Q36539475 | High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular disease |
Q36282932 | Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level |
Q39718848 | Impaired serum capacity to induce cholesterol efflux is associated with endothelial dysfunction in type 2 diabetes mellitus |
Q49578267 | Improvement of blood lipid profiles by Goishi tea polyphenols in a randomised, double-blind, placebo-controlled clinical study |
Q27664175 | In Vitro and in Vivo Analysis of the Binding of the C Terminus of the HDL Receptor Scavenger Receptor Class B, Type I (SR-BI), to the PDZ1 Domain of Its Adaptor Protein PDZK1 |
Q36708971 | Influence of PDZK1 on lipoprotein metabolism and atherosclerosis |
Q34698374 | Inhibition of mitogen-activated protein kinase Erk1/2 promotes protein degradation of ATP binding cassette transporters A1 and G1 in CHO and HuH7 cells |
Q24323192 | Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42 |
Q35150394 | Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling |
Q40306384 | Involvement of mitogen-activated protein kinases in class B scavenger receptor type I-induced phagocytosis of apoptotic cells |
Q36852328 | Lipid rafts: dream or reality for cholesterol transporters? |
Q37776742 | Lipid signaling in the atherogenesis context |
Q30942732 | Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice |
Q33717436 | Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells |
Q35572369 | Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease |
Q36406480 | Novel biological functions of high-density lipoprotein cholesterol |
Q36445823 | Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI |
Q35606603 | PDZK1 prevents neointima formation via suppression of breakpoint cluster region kinase in vascular smooth muscle |
Q35572457 | PON-dering differences in HDL function in coronary artery disease |
Q64059502 | Proline residues in scavenger receptor-BI's C-terminal region support efficient cholesterol transport |
Q35838266 | Protein mediators of sterol transport across intestinal brush border membrane |
Q35067758 | Ras/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI. |
Q48316610 | Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin |
Q35222000 | Reduction of amyloid angiopathy and Abeta plaque burden after enriched housing in TgCRND8 mice: involvement of multiple pathways |
Q34397435 | Regulation of platelet function by class B scavenger receptors in hyperlipidemia |
Q37076473 | Regulation of signal transduction by HDL. |
Q24311682 | Role of high-density lipoprotein and scavenger receptor B type I in the promotion of endothelial repair |
Q37871354 | Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein |
Q33767978 | Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI |
Q47377607 | Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering |
Q39157833 | S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization. |
Q39161542 | SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis |
Q28074790 | SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer |
Q92627442 | Scavenger Receptor Class B Type 1 (SR-B1) being a Potential Biomarker for the Diagnosis of Liposarcoma and Associated with the Degree of Differentiation of Liposarcomas |
Q42069506 | Scavenger receptor class B type I is a plasma membrane cholesterol sensor |
Q37690024 | Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development |
Q34246570 | Scavenger receptor class B type I: a multifunctional receptor |
Q33402916 | Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1 |
Q38293447 | Signal transduction by HDL: agonists, receptors, and signaling cascades |
Q90294955 | Significance of Cholesterol-Binding Motifs in ABCA1, ABCG1, and SR-B1 Structure |
Q35456261 | Stimulatory Effect of β-glucans on Immune Cells |
Q28070244 | Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging |
Q24619416 | The use of lentinan for treating gastric cancer |
Q37837679 | Update on HDL receptors and cellular cholesterol transport |
Q33784523 | Use of dansyl-cholestanol as a probe of cholesterol behavior in membranes of living cells |
Q36631208 | XenomiRs and miRNA homeostasis in health and disease: evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles |
Q43074103 | eNOS mediates TO90317 treatment-induced angiogenesis and functional outcome after stroke in mice |